A prospective examination of octreotide‐induced gall‐bladder changes in acromegaly

objective We wished to determine the effects of octreetide acetate, a somatostatin analogue, on gall‐bladder function during treatment of acromegaly

[1]  U. Plöckinger,et al.  Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly. , 1990, The Journal of clinical endocrinology and metabolism.

[2]  K. Crain.  A computer model for evaluating the costs of cholecystectomy or ursodiol treatment in the management of cholelithiasis. , 1990, Clinical therapeutics.

[3]  L. Lazarus,et al.  Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety. , 1990, Annals of internal medicine.

[4]  M. Preece,et al.  Long-term treatment of acromegaly with a long-acting analogue of somatostatin, octreotide. , 1990, The Quarterly journal of medicine.

[5]  W. Daughaday.  Octreotide is effective in acromegaly but often results in cholelithiasis. , 1990, Annals of internal medicine.

[6]  J. Wass,et al.  Gall stones and treatment with octreotide for acromegaly , 1989, BMJ.

[7]  P. Dandona,et al.  Changes in glucose tolerance after treatment for acromegaly. , 1989, BMJ.

[8]  J. McKnight,et al.  Changes in glucose tolerance and development of gall stones during high dose treatment with octreotide for acromegaly. , 1989, BMJ.

[9]  W. Hopman,et al.  Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly. , 1989, The Journal of clinical endocrinology and metabolism.

[10]  G. Bonorris,et al.  Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. , 1988, The New England journal of medicine.

[11]  S. Lamberts.  The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. , 1988, Endocrine reviews.

[12]  P. Cooperberg,et al.  Imaging of the gallbladder, 1987. , 1987, Radiology.

[13]  M. Carey,et al.  Aspirin prevention of cholesterol gallstone formation in prairie dogs. , 1981, Science.

[14]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[15]  P. Armitage,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[16]  H. Mok,et al.  Natural history of biliary stones. , 1990, Digestive diseases.

[17]  J. Wass.  Octreotide treatment of acromegaly. , 1990, Hormone research.

[18]  V. Go,et al.  Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the Gut , 1989 .

[19]  S. Lee,et al.  Origin and fate of biliary sludge. , 1988, Gastroenterology.

[20]  G. Everson,et al.  A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. , 1980, Gastroenterology.